目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Application
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT
6.1. Overview
6.2. Dialysates and Replacement Fluids
6.3. Disposables
6.3.1. Hemofilters
6.3.2. Bloodline Sets and Tubes
6.3.3. Others
6.4. CRRT System

7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY
7.1. Overview
7.2. Continuous Venovenous Hemofiltration (CVVH)
7.3. Continuous Venovenous Diafiltration (CVVHDF)
7.4. Continuous Venovenous Hemodialysis (CVVHD)
7.5. Slow Continuous Ultrafiltration (SCUF)

8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP
8.1. Overview
8.2. Geriatric
8.3. Adults
8.4. Pediatrics & Neonates

9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY END USER
9.1. Overview
9.2. Hospitals
9.3. Ambulatory Surgical Centers
9.4. Specialty Clinics

10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America

11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Continuous Renal Replacement Therapy Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Continuous Renal Replacement Therapy Market
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2021
11.8.2. Major Players R&D Expenditure. 2021

12. COMPANY PROFILES
12.1. Baxter International, Inc.
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Medtronic plc
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Fresenius Medical Care
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. B. Braun Medical Inc.
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Nikkiso Co.
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Asahi Kasei Corporation
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Toray Medical Co. Ltd
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Infomed SA
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. SWS Heamodialysis Care Co. Ltd
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Medites Pharma spol. s.r.o.
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies

13. APPENDIX
13.1. References
13.2. Related Reports
?

LIST OF TABLES
TABLE 1 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SYNOPSIS, 2018-2030
TABLE 2 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ESTIMATES & FORECAST, 2018-2030 (USD MILLION)
TABLE 3 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 4 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 5 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 6 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 7 NORTH AMERICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8 NORTH AMERICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 9 NORTH AMERICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 10 NORTH AMERICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 11 US: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 12 US: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 13 US: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 14 US: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 15 CANADA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 16 CANADA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 17 CANADA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 18 CANADA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 1 EUROPE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 2 EUROPE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 3 EUROPE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 4 EUROPE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 5 GERMANY: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6 GERMANY: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 7 GERMANY: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 8 GERMANY: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 9 FRANCE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 10 FRANCE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 11 FRANCE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 12 FRANCE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 13 ITALY: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 14 ITALY: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 15 ITALY: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 16 ITALY: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 17 SPAIN: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 18 SPAIN: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 19 SPAIN: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 20 SPAIN: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 21 UK: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22 UK: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 23 UK: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 24 UK: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 25 REST OF EUROPE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26 REST OF EUROPE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 27 REST OF EUROPE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 28 REST OF EUROPE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 33 JAPAN: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34 JAPAN: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 35 JAPAN: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 36 JAPAN: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 37 CHINA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38 CHINA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 39 CHINA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 40 CHINA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 41 INDIA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42 INDIA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 43 INDIA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44 INDIA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 45 AUSTRALIA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46 AUSTRALIA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 47 AUSTRALIA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 48 AUSTRALIA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 49 SOUTH KOREA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50 SOUTH KOREA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 51 SOUTH KOREA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 52 SOUTH KOREA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 53 REST OF ASIA-PACIFIC: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54 REST OF ASIA-PACIFIC: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 55 REST OF ASIA-PACIFIC: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56 REST OF ASIA-PACIFIC: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 57 REST OF THE WORLD: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58 REST OF THE WORLD: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 59 REST OF THE WORLD: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60 REST OF THE WORLD: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 61 MIDDLE EAST: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62 MIDDLE EAST: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 63 MIDDLE EAST: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 64 MIDDLE EAST: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 65 AFRICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66 AFRICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 67 AFRICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68 AFRICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 69 LATIN AMERICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70 LATIN AMERICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, 2018-2030 (USD MILLION)
TABLE 71 LATIN AMERICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72 LATIN AMERICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY END USER, 2018-2030 (USD MILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET
FIGURE 4 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE (%), BY PRODUCT, 2021
FIGURE 5 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE (%), BY MODALITY, 2021
FIGURE 6 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE (%), BY AGE GROUP, 2021
FIGURE 7 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE (%), BY END USER, 2021
FIGURE 8 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE (%), BY REGION, 2021
FIGURE 9 NORTH AMERICA: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 10 EUROPE: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 11 ASIA-PACIFIC: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 12 REST OF THE WORLD: GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE (%), BY REGION, 2021
FIGURE 13 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: COMPANY SHARE ANALYSIS (%), 2021
FIGURE 14 BAXTER INTERNATIONAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 BAXTER INTERNATIONAL, INC.: SWOT ANALYSIS
FIGURE 16 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 MEDTRONIC PLC: SWOT ANALYSIS
FIGURE 18 FRESENIUS MEDICAL CARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 FRESENIUS MEDICAL CARE: SWOT ANALYSIS
FIGURE 20 B. BRAUN MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 B. BRAUN MEDICAL INC.: SWOT ANALYSIS
FIGURE 22 NIKKISO CO.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 NIKKISO CO.: SWOT ANALYSIS
FIGURE 24 ASAHI KASEI CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 ASAHI KASEI CORPORATION: SWOT ANALYSIS
FIGURE 26 TORAY MEDICAL CO. LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 TORAY MEDICAL CO. LTD: SWOT ANALYSIS
FIGURE 28 INFOMED SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 INFOMED SA: SWOT ANALYSIS
FIGURE 30 SWS HEAMODIALYSIS CARE CO. LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 SWS HEAMODIALYSIS CARE CO. LTD: SWOT ANALYSIS
FIGURE 32 MEDITES PHARMA SPOL. S.R.O.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 MEDITES PHARMA SPOL. S.R.O.: SWOT ANALYSIS